Month: September 2025

Appointment strengthens Board expertise as Milestone Scientific drives commercial expansion and payer adoption of CompuFlo® in interventional pain management ROSELAND, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dawood Sayed, M.D., a nationally recognized leader in interventional pain medicine, to its Board of Directors, effective immediately. Dr. Sayed is a Professor of Anesthesiology and Pain Medicine at the University of Kansas Medical Center and currently serves as Division Chief of Pain Medicine, Director of Interventional Spine Services, and Director of the Center for Neuromodulation. With a robust clinical, academic, and policy background, he brings...

MINNEAPOLIS, Sept. 22, 2025 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that a late breaking abstract reporting clinical data from the Phase 3 VIKTORIA-1 trial has been selected for an oral presentation at the upcoming European Society of Medical Oncology (ESMO) Congress, being held October 17-21, 2025. The presentation will provide detailed efficacy and safety data from the PIK3CA wild-type cohort of the VIKTORIA-1 trial. Late Breaking Oral Presentation Details: Title: Gedatolisib + fulvestrant ± palbociclib vs fulvestrant in patients with HR+/HER2-/PIK3CA wild-type advanced breast cancer: First results from VIKTORIA-1 Abstract Number: 3535 Session Title: Proffered paper session 1: Breast Cancer, metastatic Date:...

Third patient in the first cohort is now advancing through protocol-defined evaluations as Company anticipates additional results from second dosing of second patient in the cohort SOUTH SAN FRANCISCO, Calif, Sept. 22, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company, today announced that it has dosed the third patient in the starting dose cohort of its Phase 1 clinical trial evaluating CER-1236 in acute myeloid leukemia (AML). Per protocol, three patients are planned at this lowest dose level, and enrollment of the third subject may complete the initial cohort pending the outcome of protocol-defined safety assessments, including the dose-limiting toxicity (DLT) evaluation period. Stephen Strickland, Jr., M.D., MSCI, Director of Leukemia...

Exploring potential partnerships and strategic opportunities for the Company’s stem cell therapy program in Alzheimer’s disease Alzheimer’s disease development program with positive data in successful Phase 1 and Phase 2a clinical trials Clear regulatory pathway following positive Type B meeting with U.S. FDA FDA has granted laromestrocel both Regenerative Medicine Advanced Therapy (RMAT) designation and Fast Track designation for the treatment of mild Alzheimer’s diseaseMIAMI, Sept. 22, 2025 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will participate in the Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa taking place October...

Prime 1,600-acre Nassau County property offers power, water, fiber connectivity and expansion capacity for phased AI and cloud infrastructure growth MIAMI, Sept. 22, 2025 (GLOBE NEWSWIRE) — NextNRG (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today announced it has secured a long-term lease option on 1,600 acres in Nassau County. The company is advancing plans for a potential deployment of a 200 MW smart microgrid that would utilize roughly 1,200 acres of the property. The remaining 400 acres are ideally positioned for hyperscale data center development, offering operators ample land in a location with power, water, and fiber already in place. Strategically located near Jacksonville International Airport, the property offers ample expansion capacity with direct...

Cardano’s Scalable, Peer-Reviewed Blockchain Strengthens Treasury Strategy LAKEWOOD, NJ, Sept. 22, 2025 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today announced that it has completed its first purchase of Cardano (ADA) under its recently launched Digital Asset Treasury (“DAT”) initiative. With this investment, Reliance strengthens its digital asset treasury by adding Cardano, recognized for its peer-reviewed, scalable blockchain, energy-efficient proof-of-stake design, and growing real-world adoption. This purchase follows Reliance’s initial purchase of Ethereum (ETH) earlier this month and reflects the Company’s ongoing commitment to building a diversified portfolio of leading digital assets. Reliance’s DAT initiative is designed to pursue long-term capital appreciation...

Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the high-throughput carrier screening market with a significantly expanded and enhanced suite of PureTarget products. The updated solutions leverage PacBio’s highly accurate HiFi sequencing technology to allow clinical laboratories to consolidate multiple specialized assays into a single, scalable test capable of resolving some of the most challenging genes associated with inherited conditions. Recent research shows that up to 71% of individuals carry at least one pathogenic variant, highlighting the growing importance of...

PHOENIX, Sept. 22, 2025 (GLOBE NEWSWIRE) — The Marquie Group, Inc. (“TMGI” or the “Company”) (OTCID:TMGI) today announced that it has entered into a purchase agreement with GETGOLF.COM marking a new era for the Company. Under the agreement, TMGI CEO Marc Angell will transfer control shares to GETGOLF.COM and its CEO, Jeff Foster, a highly accomplished veteran in the Golf and Hospitality Industry. The transition is expected to occur swiftly upon completion of closing procedures and the transfer of assets. Outgoing CEO Marc Angell stated, “Jeff Foster’s exceptional experience in managing golf businesses makes him the ideal successor for TMGI. Shareholders will be pleased to know that, as part of this agreement, Jeff is bringing profitable ventures that are expected to propel the company forward for years to come. I am enthusiastic...

Elraglusib represents a potential back bone therapy in pancreatic cancer with three ongoing trials in combination with current standards of care and novel immunotherapies Recent financing provides extended runway through key anticipated regulatory inflection points Additional nonclinical studies are ongoing combining elraglusib with RAS inhibitors based on potential synergies and complimentary mechanisms of actionCHICAGO and FORT WORTH, Texas, Sept. 22, 2025 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), today announced a corporate update on the regulatory path for elraglusib in pancreatic...

Best-in-Class Technology to Help Cities Optimize Streetlight Performance and Expand IoT Capabilities LIBERTY LAKE, Wash., Sept. 22, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, is entering a joint marketing agreement with Current Lighting Solutions – (Current), a provider of sustainable, advanced lighting, to deliver a combined smart lighting solution designed to maximize the safety, energy efficiency and operational benefits of enhanced luminaire technology. The combined offering brings together Itron’s best-in-class management and control technologies, as part of its CityEdge portfolio, with Current’s industry leading LED fixtures and luminaries, including its Evolve® Roadway product line. By bringing together Current’s high-efficiency LED...